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CASE REPORT
Fig. 1. The erythematous nodule based on an irregular shaped 
erythematous patch is seen on the left mandibular angle.
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Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous 
malignancy of the elderly and immunocompromised 
patients. It is occasionally found coexisting with other 
diseases, such as squamous cell carcinoma, basal cell 
carcinoma, actinic keratosis, miscellaneous adnexal tumors, 
and rarely Bowen disease. A 75-year-old woman presented 
with a 6-month history of an irregularly shaped erythematous 
patch on the left mandibular angle. Three months later, a 
1.5×1.0 cm sized painless and rapidly growing erythem-
atous nodule developed on the patch. Microscopically, the 
patch lesion was consistent with that of Bowen disease. The 
nodular lesion showed a number of small uniform 
hyperchromatic cells with scanty cytoplasm. It showed 
dense small-cell like nodular infiltration in the dermis. 
Immunohistochemical staining for cytokeratin 20 showed a 
positive result with a dot-like perinuclear pattern. Additionally, 
the result for thyroid transcription factor-1 was negative, 
which is positive in small cell neuroendocrine carcinoma. 
From these findings, we diagnosed this lesion as MCC 
concurrent with Bowen disease. (Ann Dermatol 24(1) 77∼
80, 2012)
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INTRODUCTION
Merkel cell carcinoma (MCC), also referred to as cuta-
neous neuroendocrine carcinoma, is an uncommon malig-
nancy that has a predilection for locoregional recurrence 
and distal metastasis
1. It is characterized by a painless, 
red-purple colored nodule or an indurated plaque on a 
sun-exposed area. It usually arises in the head and neck of 
elderly people and tends to be more common in men
1. 
Although it is usually found as a solitary lesion, it is 
occasionally found to coexist with other malignancies, 
such as squamous cell carcinoma, basal cell carcinoma, 
and rarely Bowen disease
2. Herein, we report an inter-
esting case of MCC concurrent with Bowen disease.HC Park, et al
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Fig. 2. (a) “Windblown appearance” of the epidermis on the patch lesion (H&E, ×200). (b) Numerous small uniform tumor cells 
with round hyperchromatic nuclei and scanty cytoplasm are arranged nodular infiltration in the dermis on the nodular lesion (H&E, 
×100). (c) Cytokeratin 20 was stained positive in a dot-like perinuclear pattern (×200). (d) Immunohistochemical staining of tumor 
cells showing negativity for thyroid transcription factor 1 (×200).
CASE REPORT
A 75-year-old woman presented with a 6-month history of 
an irregularly shaped erythematous patch on the left 
mandibular angle (Fig. 1). Three months later, a 1.5×1.0 
cm sized painless and rapidly growing erythematous 
nodule developed on the patch. Her medical history and 
family history were unremarkable, and there was no 
history of chronic trauma to the left cheek. Laboratory 
findings, including complete blood count, blood chemistry, 
and routine urinalysis, were normal. The skin biopsy 
specimens were taken from the surrounding erythematous 
patch and the nodular lesion, respectively. Histopatho-
logically, the patch lesion showed full-thickness kera-
tinocytic atypia resulting in a “windblown appearance” of 
the epidermis, consistent with Bowen disease (Fig. 2a). 
The nodular lesion showed numerous small uniform cells 
with round hyperchromatic nuclei and scanty cytoplasms 
(Fig. 2b). We regarded this lesion as a malignant lymphoma 
and performed special stains. However, stain results for 
these cells were negative to pan T cell (CD3) and pan B 
cell (CD79a and CD20) markers. The immunohistochemical 
stain results for chromogranin and synaptophysin were 
focally positive, and the result for cytokeratin 20 (CK20) 
was positive with a dot-like perinuclear pattern (Fig. 2c). 
Additionally, the stain result for thyroid transcription 
factor-1 (TTF-1) to perform the differential diagnosis 
between MCC and small cell lung cancer was negative 
(Fig. 2d). From these findings, we diagnosed this lesion as 
a MCC concurrent with Bowen disease. The evaluations 
for systemic involvement and surgical treatment were 
recommended. Consequently, she was transferred to the 
plastic surgery department, but she just received a 
palliative treatment.Merkel Cell Carcinoma
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Table 1. Summary of reported cases of MCC concurrent with Bowen disease
No. Authors Sex/Age Involved site Skin lesion Therapy
1 Schenk and Konrad
5 (1991) F/79 Left temporal scalp Erythematous nodule SE & RT
2 Okamoto et al.
6  (1998) F/74 Left cheek Erythematous papule on a brownish macule SE
3T s u r u t a  e t  a l .
7  (1998) M/72 Left sole Reddish tumor with sharp border SE
4 Moon et al.
8 (2004) M/42 Left forearm Solitary, dome shaped reddish nodule SE &
 surrounded by erythematous scaly patch  Cryotherapy
5 Sarma et al.
9 (2007) F/88 Left thigh Solitary, nodule surrounded by SE
 erythematous patch
6 Sirikanjanapong et al.
2 (2010) M/85 Scalp Erythematous crusted nodule SE
7 Our case (2010) F/75 Left cheek Erythematous nodule based on Cryotherapy 
 an erythematous plaque  & RT
MCC: Merkel cell carcinoma, F: female, M: male, SE: surgical excision, RT: radiation therapy.
DISCUSSION
MCC is a primary cutaneous carcinoma, which is a rare 
malignant tumor that was described first as a trabecular 
carcinoma of the skin by Toker
3 in 1972. Although the 
exact origin of the MCC is unknown, Tang and Toker
4 
suggested in 1978 that tumor cells may arise from Merkel 
cells because the cells contain electron-dense core granules 
which are believed to be a feature of Merkel cells.
Histopathologically, the epidermis is involved in less than 
10% of all MCC cases, and the tumor cells are located in 
the dermis and grow toward subcutaneous tissue, with a 
tendency to infiltrate vascular and lymphatic vessels
1,2. 
The tumor cells are uniformly sized basophilic cells, with 
round or oval nuclei and small nucleoli. Immunohisto-
chemical stains are useful for differential diagnosis 
between MCC and other cutaneous tumors. CK20, which 
is the most widely used and the single most useful 
immunohistochemical stain in the work-up of MCC, is 
positive; its perinuclear dot-like expression is the hallmark 
staining pattern in MCC. Additionally, the tumor cells 
stain positively for neuron-specific enolase, chromogranin, 
synaptophysin, and neurofilaments. Staining for S100 
protein, TTF-1, glial fibrillary acidic protein, actin, vimentin, 
and leukocyte common antigen
1 is negative. In our case, 
the tumor cells were negative for pan T cell (CD3) and 
pan B cell (CD79a and CD20) markers, positive for CK20, 
and negative for TTF-1.
MCC is usually found as a solitary lesion but is 
occasionally found to coexist with other diseases, such as 
squamous cell carcinoma, basal cell carcinoma, actinic 
keratosis, miscellaneous adnexal tumors, and rarely Bowen 
disease (Table 1)
1,2,5-9. Two theories are postulated to 
explain these observations. Smith et al.
10 suggested that 
MCC may arise from a primitive pluripotent stem cell that 
has the capacity to differentiate along different cell lines. 
They reviewed 132 MCCs and found 11 cases with an 
intraepidermal component and focal squamous and/or 
eccrine differentiation. On the other hand, Gomez et al.
11 
suggested that there may be a possible common 
carcinogenic influence on different precursor cells of the 
skin that cause the coexistence of different tumors. They 
described 11 cases of MCC associated with invasive 
squamous cell carcinoma in the same area. When the 
neoplasms were coexisting, there was never a suggestion 
of continuity between them, and transitional cell forms 
were not seen. 
The exact cause of why both MCC and Bowen disease can 
exist concurrently is still unknown to us. It has been 
reported that some cases of MCC are concurrent with 
Bowen disease occurring in the same region synchro-
nously
2,5-9. Several studies suggested that arsenic is a 
carcinogen that may induce the occurrence of MCC in 
addition to squamous cell carcinoma, basal cell carcinoma, 
and Bowen disease
7,8,12. In the past, it was common to 
take pills which included arsenic. Our patient did not 
remember whether she took pills in the past due to her 
old age. So we tried to get information from her family, 
but we could not find any proof of arsenic exposure 
during her history. Considering these facts, we can 
suppose that MCC and Bowen disease occured incidentally 
to our patient.
The preferred treatment at present is surgical excision with 
sentinel lymph node biopsy followed by lymph node 
dissection if the latter is positive. Postoperative radiotherapy 
is also given, and this approach improves locoregional 
control, in addition to disease-free survival. Chemotherapy 
is not routinely recommended, as it does not increase 
overall survival
1,8.
We clinically observed a case of the MCC concurrent with 
Bowen disease occurring at a sun exposure location and 
without any known risk factors. It is a rare case in the 
dermatologic literature; thus, physicians should consider 
that MCC could be included in the differential diagnosis of HC Park, et al
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nodular lesions in Bowen disease.
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